Response

We thank Drs Gaballa and Moyer1 for their interest in our recently published article.2 Their recommendation to use a standardized lexicon for adverse events (AEs) is of great value. The AE rate in our study was 8.3% (3/36). It was revealed that EUS-guided ablation with ethanol with or without paclitaxel injection was fairly safe, with an AE rate of 10% to 15%.3 The advantage of lauromacrogol seemed to be weak compared with ethanol in treatment safety. In our opinion, lauromacrogol may have an advantage over ethanol for its anesthetic effect of relieving pain during and after surgery.

https://ift.tt/2EEc6ax